Busse WW - Search Results

1

Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.

Djukanović R, Wilson SJ, Kraft M, Jarjour NN, Steel M, Chung KF, Bao W, Fowler-Taylor A, Matthews J, Busse WW, Holgate ST, Fahy JV. Djukanović R, et al. Among authors: busse ww. Am J Respir Crit Care Med. 2004 Sep 15;170(6):583-93. doi: 10.1164/rccm.200312-1651OC. Epub 2004 Jun 1. Am J Respir Crit Care Med. 2004. PMID: 15172898 Clinical Trial.

2

Relationship of plasma epinephrine and circulating eosinophils to nocturnal asthma.

Bates ME, Clayton M, Calhoun W, Jarjour N, Schrader L, Geiger K, Schultz T, Sedgwick J, Swenson C, Busse W. Bates ME, et al. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):667-72. doi: 10.1164/ajrccm.149.3.8118634. Am J Respir Crit Care Med. 1994. PMID: 8118634

3

Airway remodeling and repair.

Busse W, Elias J, Sheppard D, Banks-Schlegel S. Busse W, et al. Am J Respir Crit Care Med. 1999 Sep;160(3):1035-42. doi: 10.1164/ajrccm.160.3.9902064. Am J Respir Crit Care Med. 1999. PMID: 10471638 No abstract available.

4

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.

Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N. Busse W, et al. J Allergy Clin Immunol. 2001 Aug;108(2):184-90. doi: 10.1067/mai.2001.117880. J Allergy Clin Immunol. 2001. PMID: 11496232 Clinical Trial.

5

Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge.

Liu LY, Sedgwick JB, Bates ME, Vrtis RF, Gern JE, Kita H, Jarjour NN, Busse WW, Kelly EA. Liu LY, et al. Among authors: busse ww. J Immunol. 2002 Dec 1;169(11):6452-8. doi: 10.4049/jimmunol.169.11.6452. J Immunol. 2002. PMID: 12444154

6

A comparison of the airway response to segmental antigen bronchoprovocation in atopic asthma and allergic rhinitis.

Becky Kelly EA, Busse WW, Jarjour NN. Becky Kelly EA, et al. Among authors: busse ww. J Allergy Clin Immunol. 2003 Jan;111(1):79-86. doi: 10.1067/mai.2003.28. J Allergy Clin Immunol. 2003. PMID: 12532100

7

Comparison of the effects of repetitive low-dose and single-dose antigen challenge on airway inflammation.

Liu LY, Swenson CA, Kelly EA, Kita H, Jarjour NN, Busse WW. Liu LY, et al. Among authors: busse ww. J Allergy Clin Immunol. 2003 Apr;111(4):818-25. doi: 10.1067/mai.2003.1346. J Allergy Clin Immunol. 2003. PMID: 12704364

8

Rhinovirus-induced interferon-gamma and airway responsiveness in asthma.

Brooks GD, Buchta KA, Swenson CA, Gern JE, Busse WW. Brooks GD, et al. Among authors: busse ww. Am J Respir Crit Care Med. 2003 Nov 1;168(9):1091-4. doi: 10.1164/rccm.200306-737OC. Epub 2003 Aug 19. Am J Respir Crit Care Med. 2003. PMID: 12928311

9

Chemokine receptor expression on human eosinophils from peripheral blood and bronchoalveolar lavage fluid after segmental antigen challenge.

Liu LY, Jarjour NN, Busse WW, Kelly EA. Liu LY, et al. Among authors: busse ww. J Allergy Clin Immunol. 2003 Sep;112(3):556-62. doi: 10.1016/s0091-6749(03)01798-6. J Allergy Clin Immunol. 2003. PMID: 13679815

10

Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma.

Liu L, Jarjour NN, Busse WW, Kelly EA. Liu L, et al. Among authors: busse ww. Am J Respir Crit Care Med. 2004 May 15;169(10):1118-24. doi: 10.1164/rccm.200312-1659OC. Epub 2004 Mar 4. Am J Respir Crit Care Med. 2004. PMID: 15001464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

584 results

Search Page